MAI Wealth Advisors »

Oramed Pharm shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Oramed Pharm (ORMP) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Oramed Pharm

Tip: Access up to 7 years of quarterly data

All positions including Oramed Pharm held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oramed Pharm by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.4k 2.1k 2.64
2025-06-30 $4.6k 2.1k 2.25
2025-03-31 $4.4k 2.1k 2.14

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Alphabet Call Call Option (Principal) (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Oramed Pharm

BML Capital Management
Murchinson
Boothbay Fund Management
Rathbones Brothers
Renaissance Technologies
Dimensional Fund Advisors
Wells Fargo & Company
Citadel Advisors
BlackRock
Jane Street
Rbf Capital
Susquehanna International
Morgan Stanley
Squarepoint Ops
Connor, Clark & Lunn Investment Management

View all funds holding Oramed Pharm